CPDR Patient Education Program
Special Clinic at WRNMMC for Men with Prostate Cancer
The Center for Prostate Disease Research (CPDR) at Walter ReedNational Military Medical Center (WRNMMC) has a special clinic for men diagnosed with prostate cancer called the "Multi-Disciplinary Prostate Cancer Clinic".
What is the purpose of the clinic?
To provide men (and their families) with information about their prostate cancer so they can make an informed decision on the best treatment for them.
Who is eligible to attend?
Military health care beneficiaries who are diagnosed with prostate cancer and have not yet made a treatment decision.
Why is it called "Multi-Disciplinary"?
Because men (and their families) will see staff members from a variety of disciplines --- surgery, radiation, sexual health, psychology, nursing, and research. The clinic is convenient and comprehensive by bringing everyone together on one day.
It is a comprehensive, multi-disciplinary, team-focused clinic. The goal of the clinic is to give men the medical team's recommendation on the best treatment (or treatments) for their prostate cancer based on their individual situation, and to provide information so they can make an informed decision on a treatment.
What happens in the clinic?
Each man (and their family) attending the clinic has 4 private consultations:
2) radiation oncologist
3) urologist specializing in male sexual health and
There will also be 3 small group sessions:
1) welcome and orientation to the clinic
2) patient education and
3) research opportunities.
At the end of the clinic, a physician meets with each man privately to discuss the treatment (or treatments) that the medical team recommends.
How do I get into the clinic?
An appointment is required. (There is a maximum of 6 men for each clinic). Self-referrals are accepted. Call CPDR at 301-319-2900 for more information or to make an appointment.
When and where is the clinic conducted?
The clinic is held on Mondays at WRNMMC at the Center for Prostate Disease Research Clinic is conducted at WRNMMC
8901 Wisconsin Avenue, Bethesda, MD 20889.
America Building (Bldg #19), 3rd floor.
Parking is available in America Garage behind the America Building.
Hospital is located across from the National Institutes of Health, National Library of Medicine, and the Metro station ("Medical Center" red line).
September 29, 2014
Genomic Health Announces Positive Results from Latest Clinical Validation Study of Oncotype DX® as Predictor of Near- and Long-term Outcomes in Racially Diverse Group of Prostate Cancer Patients
REDWOOD CITY, CA – Genomic Health, Inc. (Nasdaq: GHDX) today announced strongly positive results from an additional independent clinical validation study of the Oncotype DX® prostate cancer test, conducted in collaboration with the Uniformed Services University of the Health Sciences' (USU) Center for Prostate Disease Research (CPDR) supported by a multi-disciplinary team of investigators under a cooperative research and development agreement with USU. This new large study reconfirmed the biopsy-based test's Genomic Prostate Score (GPS) as a predictor of adverse pathology at surgery and, for the first time, validated GPS as a strong independent predictor of a rise in prostate-specific antigen (PSA) following surgery (biochemical recurrence).
Read Full Article.
Read Publication - European Urology
Read the NOVEMEBR 2014 Newsletter